AVADEL PHARMACEUTICALS PLC
SPONSORED ADR · CUSIP 05337M104
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $14.06.
Trends to Q2 2024
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 77 |
| Q4 2022 | 83 |
| Q1 2023 | 93 |
| Q2 2023 | 102 |
| Q3 2023 | 100 |
| Q4 2023 | 115 |
| Q1 2024 | 120 |
| Q2 2024 | 10 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q4 2022 | 39 | 29 |
| Q1 2023 | 53 | 26 |
| Q2 2023 | 56 | 40 |
| Q3 2023 | 49 | 42 |
| Q4 2023 | 52 | 35 |
| Q1 2024 | 72 | 55 |
| Q2 2024 | 3 | 112 |
Calls vs puts
Options held, notional value, last 4 quarters. P/C = puts ÷ calls
Numbers
| Quarter | Calls | Puts | P/C |
|---|---|---|---|
| Q3 2023 | $11.0m | $3.4m | 0.31 |
| Q4 2023 | $15.6m | $5.0m | 0.32 |
| Q1 2024 | $24.3m | $45.1m | 1.86 |
| Q2 2024 | $0 | $0 | — |
Biggest buyers
| Ameritas Investment Partners, Inc. | New | +9.1k |
| 1620 INVESTMENT ADVISORS, INC. | New | +1.0k |
| Tri Locum Partners LP | Added | +7 |
Biggest sellers
| JANUS HENDERSON GROUP PLC | Sold out | -12.9m |
| RTW INVESTMENTS, LP | Sold out | -8.8m |
| Polar Capital Holdings Plc | Sold out | -6.8m |
| GENDELL JEFFREY L | Sold out | -5.7m |
| BRAIDWELL LP | Sold out | -2.7m |
| WEALTH EFFECTS LLC | Sold out | -2.3m |
| MORGAN STANLEY | Sold out | -2.0m |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | Sold out | -1.9m |
| MILLENNIUM MANAGEMENT LLC | Sold out | -1.8m |
| CITADEL ADVISORS LLC | Sold out | -1.6m |
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
No one currently above 5% in the filings since 19 Dec 2024.
Fell to 5% or below in the last year: GENDELL JEFFREY L (4.9%, 2026-02-06)
Holders, Q2 2024
| Manager | Shares | Change |
|---|---|---|
| Vivo Capital, LLC 5.16% of their portfolio | 4.0m $55.8m | Unchanged |
| Tri Locum Partners LP 4.23% of their portfolio | 1.2m $16.7m | Added +7 |
| MPM BIOIMPACT LLC 1.71% of their portfolio | 783.2k $11.0m | Reduced -87.9k |
| Knoll Capital Management, LLC 5.68% of their portfolio | 600.0k $8.4m | Unchanged |
| Knott David M Jr 1.87% of their portfolio | 333.0k $4.7m | Unchanged |
| SCHULHOFF & CO INC 0.87% of their portfolio | 137.0k $1.9m | Unchanged |
| Ameritas Investment Partners, Inc. 0.00% of their portfolio | 9.1k $127.3k | New |
| 1620 INVESTMENT ADVISORS, INC. 0.01% of their portfolio | 1.0k $14.1k | New |
| CWM, LLC 0.00% of their portfolio | 99 $1.0k | Unchanged |
| HUNTINGTON NATIONAL BANK 0.00% of their portfolio | 1 $16 | Unchanged |